{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:39:47Z","timestamp":1777052387444,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.htct.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T08:46:41Z","timestamp":1725698801000},"page":"103682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil"],"prefix":"10.1016","volume":"47","author":[{"given":"Larissa Hilario","family":"Dulley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9223-9139","authenticated-orcid":false,"given":"Arthur Gomes Oliveira","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme Garcia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Costa","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos S\u00e9rgio","family":"Chiattone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talita Maira Bueno","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2024.06.003_bib0001","series-title":"Leukemia","article-title":"The 5th edition of the world health organization classification of hematolymphoid tumors","author":"Li","year":"2022"},{"issue":"1","key":"10.1016\/j.htct.2024.06.003_bib0002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma published correction appears in Nat Rev Dis Primers","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"10310","key":"10.1016\/j.htct.2024.06.003_bib0003","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice","year":"2021","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.htct.2024.06.003_bib0004","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.htct.2024.06.003_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11899-007-0022-2","article-title":"MD Is BEACOPP better than ABVD?","volume":"2","author":"Cheson","year":"2007","journal-title":"Curr Hematol Malig Rep"},{"issue":"8","key":"10.1016\/j.htct.2024.06.003_bib0006","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/annonc\/mdu189","article-title":"ABVD (8 cycles) versus BEACOPP (4 escalated cycles \u22654 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial","volume":"25","author":"Mounier","year":"2014","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.htct.2024.06.003_bib0007","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2008.17.0910","article-title":"ABVD Compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial","volume":"27","author":"Massimo","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.htct.2024.06.003_bib0008","first-page":"1564","article-title":"Procarbazine-free escalated BEACOPDAC in frontline therapy of advanced Hodgkin in lymphoma reduces red cell transfusion requirements and may shorten time to menstrual period recovery compared to escalated BEACOPP and appears to be efficacious","volume":"134","author":"Anna","year":"2019","journal-title":"Blood"},{"issue":"31\u201332","key":"10.1016\/j.htct.2024.06.003_bib0009","first-page":"535","article-title":"Hodgkin lymphoma in adults: diagnosis, treatment, and follow-up","volume":"115","author":"Br\u00f6ckelmann","year":"2018","journal-title":"Clinical Practice Guideline"},{"key":"10.1016\/j.htct.2024.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2019.03.016","article-title":"Neutropenia during frontline treatment of advanced Hodgkin lymphoma: incidence, risk factors, and management","volume":"138","author":"Gautam","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.htct.2024.06.003_bib0011","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood-2021-146242","article-title":"Real world escalated beacopdac delivers similar outcomes to escalated BEACOPP and superior outcomes to response-adapted (RATHL) ABVD, while potentially reducing toxicity compared with escalated BEACOPP","volume":"138","author":"Santarsieri","year":"2021","journal-title":"Blood"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:02:28Z","timestamp":1741870948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137924003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2531137924003067"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2024.06.003","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103682"}}